• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SEPTODONT, INC. BIOROOT RCS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SEPTODONT, INC. BIOROOT RCS Back to Search Results
Model Number 01E0300
Device Problem Appropriate Term/Code Not Available (3191)
Patient Problems Necrosis (1971); Swelling (2091)
Event Date 09/20/2017
Event Type  Injury  
Event Description
Spontaneous report, (b)(4).Initial information received on 21-sep-2017 from the dentist by phone.The dentist reported that a (b)(6) female patient, with medical history of allergy multiple, penicillin and aspirin allergy, dental fistula and broken tooth #21, received an unknown dose of the suspected septanest 40 mg/ml with adrenaline 1/200.000 solution for injection (articaine hydrochloride; epinephrine bitartrate), by dental route for local anaesthesia before a root canal procedure with the medical device bioroot rcs (batch b18997, exp 08/2018), on (b)(6) 2017.The patient had previously been treated with septanest 40 mg/ml with adrenaline 1/200.000, without complications.On (b)(6) 2017, at the end of dental procedure, the dentist noted a gingival swelling without inflammatory reaction (no redness), and the patient experienced soft tissue necrosis rather whitish appearance.During the root canal treatment, the dentist used a disinfectant (paroex) for cleaning the root, without reaction of the patient.The dentist confirmed there was no periapical extrusion of product.On (b)(6) 2017, the dentist saw again the patient and extension of swelling from cheek to eye was noted.The dentist removed the medical device bioroot rcs, and prescribed an anti inflammatory, flanid (tiaprofenic) and an homeopathic treatment with apis mellifica.Posology and therapy duration were not provided.At the time of this report, the patient was recovering.An interview was planned within 2 weeks.The dentist suspected an allergic reaction to the medical device bioroot rcs.Additional information received on 25-sep-2017 from the dentist by phone provided regarding patient's outcome, no periapical overfilling was done, and trade name of disinfectant used during dental treatment.Causality assessment on 29-sep-2017 on initial information received on 21-sep-2017: seriousness: serious (ime list term > other medically important condition).Listedness/expectedness: soft tissue necrosis: unexpected eu/us/ca; facial swelling: unexpected eu/us/ca.Gingival swelling: unexpected eu/us/ca.Causality: latency: suggestive, recognized association: no, analysis: in this case, swelling and local reaction occurred after the dental procedure.Swelling after root canal treatment is described, and these reactions are probably related to the endodontic procedure including shaping, canal irrigation and canal filling.However in this patient with medical history of multiple allergies, product hypersensitivity cannot be excluded.Moreover since patient recovered after removal of the cement, the causality between bioroot and facial and gingival swelling was assessed as possible.Regarding soft tissue necrosis, the local injection with vasoconstrictor may be an etiology but very few information is provided regarding this reaction and outcome was unknown.This must be a complication of dental fistula and abscess which seems the most probably etiology.Therefore, the causality between bioroot and soft tissue necrosis was assessed as unlikely.Dechallenge: na, rechallenge: na.Concluded causality who: unlikely for soft tissue necrosis, possible for facial swelling and gingival swelling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BIOROOT RCS
Type of Device
BIOROOT RCS
Manufacturer (Section D)
SEPTODONT, INC.
416 s. taylor avenue
louisville CO 80270
Manufacturer (Section G)
SEPTODONT INC.
416 south taylor ave.
louisville CO 80027
Manufacturer Contact
lawrence kass
416 south taylor ave.
louisville, CO 80027
3036657535
MDR Report Key6968516
MDR Text Key89961904
Report Number0001721729-2017-00010
Device Sequence Number1
Product Code KIF
UDI-Device Identifier03760140703373
UDI-Public03760140703373
Combination Product (y/n)Y
PMA/PMN Number
K130601
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial
Report Date 10/20/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/23/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Dentist
Device Expiration Date08/31/2018
Device Model Number01E0300
Device Lot NumberB18997
Was the Report Sent to FDA? No
Date Manufacturer Received10/04/2017
Patient Sequence Number1
Treatment
SEPTANEST 40 MG/ML ADRÉNALINÉE AU 1/200.000
Patient Outcome(s) Other;
-
-